Skip to main content

Advertisement

SpringerLink
Log in

A retrospective review of XEN implant surgery: efficacy, safety and the effect of combined cataract surgery

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Objectives

To investigate the safety and efficacy of glaucoma XEN stent implantation and examine the effect of undergoing combined phacoemulsification and XEN versus XEN implant alone.

Methods

A retrospective case note review of patients who underwent XEN implantation by a single surgeon over a 24-month period was performed. Outcomes included changes in IOP and medication use after XEN implant insertion as well as complications post-surgery. Subgroup analysis was also performed, separating phaco-XEN (phacoemulsification and XEN implantation) and stand-alone XEN implantation.

Results

186 XEN implant procedures were included in this study from a total of 143 patients. Intraocular pressure changes with time were as follows: preoperative 18.1 mmHg (± 5.77), 6 months 13.2 mmHg (SD ± 3.9), 12 months 13.7 mmHg (SD ± 5.6) and 24 months 12.6 mmHg (SD ± 3.1). For visits up to 12 months, comparison from preoperative IOP was significant at the < 0.0001 level; for 18 and 24 months, significance was < 0.05. Medication usage with time was as follows: preoperative 2.5 (SD ± 1.1) 6 months 0.7 (SD ± 0.9), 12 months 0.8 (SD ± 0.97), and 24 months 1.7 (SD ± 1.7). All results were significant at < 0.05 level. Subgroup analysis of separate phaco-XEN and stand-alone XEN groups did not reveal significant differences in IOP; however, there was a significant difference between the two groups preoperatively. Initial hypotony occurred in 75 cases (40%). There were 9 cases of hypotonous maculopathy, 3 cases of persistent choroidal effusions, 3 cases of IOP spikes, 1 cases of cyclodialysis cleft and 1 case of corneal decompensation. 25 (13%) cases had needling during their treatment.

Conclusion

The XEN implant appears to be safe and effective at reducing intraocular pressure and medication usage in glaucoma patients. XEN implantation is an effective treatment option for a range of glaucoma types and can be used as a stand-alone procedure or combined with cataract surgery to treat glaucoma patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Pascolini D, Mariotti SP (2012) Global estimates of visual impairment: 2010. Br J Ophthalmol 96(5):614–618

    Article  Google Scholar 

  2. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262–267

    Article  CAS  Google Scholar 

  3. Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311(18):1901–2191

    Article  Google Scholar 

  4. Leske MC, Heijl A, Hyman L et al (1999) Early manifest glaucoma trial: design and baseline data. Ophthalmology 106:2144–2153

    Article  CAS  Google Scholar 

  5. Gazzard G, Konstantakopoulou E, Garway-Heath D et al (2019) Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet 393(10180):1505–1516

    Article  Google Scholar 

  6. Lin S (2006) Building a safer trabeculectomy. Br J Ophthalmol 90(1):4–5

    Article  CAS  Google Scholar 

  7. Fea AM, Durr GM, Marolo P, Malinverni L, Economou MA, Ahmed I (2020) XEN® Gel Stent: a comprehensive review on its use as a treatment option for refractory glaucoma. Clin Ophthalmol 14:1805–1832

    Article  CAS  Google Scholar 

  8. Sheybani A, Reitsamer H, Ahmed II (2015) Fluid dynamics of a novel micro-fistula implant for the surgical treatment of glaucoma. Invest Ophthalmol Vis Sci 56(8):4789–4795

    Article  CAS  Google Scholar 

  9. Karimi A, Lindfield D, Turnbull A et al (2019) A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery. Eye (Lond) 33(3):469–477

    Article  Google Scholar 

  10. Gabbay IE, Allen F, Morley C, Pearsall T, Bowes OM, Ruben S (2020) Efficacy and safety data for the XEN45 implant at 2 years: a retrospective analysis. Br J Ophthalmol 104(8):1125–1130

    Article  Google Scholar 

  11. Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I (2017) Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma 26(12):1130–1136

    Article  Google Scholar 

  12. Pérez-Torregrosa VT, Olate-Pérez Á, Cerdà-Ibáñez M et al (2016) Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Cirugía combinada mediante facoemulsificación e implante XEN45 con acceso temporal y 2 únicas incisiones. Arch Soc Esp Oftalmol 91(9):415–421

    Article  Google Scholar 

  13. Grover DS, Flynn WJ, Bashford KP et al (2017) Performance and safety of a new Ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol 183:25–36

    Article  Google Scholar 

  14. Widder RA, Kühnrich P, Hild M, Rennings C, Szumniak A, Rössler GF (2019) Intraocular degradation of XEN45 gel stent 3 years after its implantation. J Glaucoma. https://doi.org/10.1097/IJG.0000000000001364

    Article  PubMed  Google Scholar 

  15. De Gregorio A, Pedrotti E, Russo L, Morselli S (2018) Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol 38(3):1129–1134

    Article  Google Scholar 

  16. Tan SZ, Walkden A, Au L (2018) One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye (Lond) 32(2):324–332

    Article  Google Scholar 

  17. Heidinger A, Schwab C, Lindner E, Riedl R, Mossböck G (2019) A Retrospective study of 199 Xen45 stent implantations from 2014 to 2016. J Glaucoma 28(1):75–79

    Article  Google Scholar 

  18. Mansouri K, Guidotti J, Rao HL et al (2018) Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results. J Glaucoma 27(2):140–147

    Article  Google Scholar 

  19. Reitsamer H, Sng C, Vera V et al (2019) Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 257(5):983–996

    Article  CAS  Google Scholar 

  20. Widder RA, Dietlein TS, Dinslage S, Kühnrich P, Rennings C, Rössler G (2018) The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries. Graefes Arch Clin Exp Ophthalmol 256(4):765–771

    Article  Google Scholar 

  21. Fea AM, Bron AM, Economou MA et al (2020) European study of the efficacy of a cross-linked gel stent for the treatment of glaucoma. J Cataract Refract Surg 46(3):441–450

    Article  Google Scholar 

  22. Shingleton BJ, Pasternack JJ, Hung JW, O’Donoghue MW (2006) Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma 15(6):494–498

    Article  Google Scholar 

  23. Slabaugh MA, Bojikian KD, Moore DB, Chen PP (2014) The effect of phacoemulsification on intraocular pressure in medically controlled open-angle glaucoma patients. Am J Ophthalmol 157(1):26–31

    Article  CAS  Google Scholar 

  24. Chen PP, Lin SC, Junk AK, Radhakrishnan S, Singh K, Chen TC (2015) The Effect of phacoemulsification on intraocular pressure in glaucoma patients: a report by the American academy of ophthalmology. Ophthalmology 122(7):1294–1307

    Article  Google Scholar 

  25. Karimi A, Lindfield D (2018) Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed? Clin Ophthalmol 12:2331–2335

    Article  Google Scholar 

  26. Rosner B, Ying G-S, Glynn R, Maguire MG (2017) Statistical analysis for correlated binary ophthalmologic data. Invest Ophthalmol Vis Sci 58(8):1529

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ophthalmology Department, Colchester Eye Centre of Excellence, East Suffolk and North Essex NHS Foundation Trust, Turner Road, Mile End, Colchester, CO4 5JR, ESSEX, UK

    Symeon Nicolaou, Tasneem Z. Khatib, Zhiheng Lin, Twishaa Sheth, Golden Ogbonna, Lamia Hamidovic, Asad Zaheer & Chrysostomos Dimitriou

Authors
  1. Symeon Nicolaou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tasneem Z. Khatib
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhiheng Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Twishaa Sheth
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Golden Ogbonna
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lamia Hamidovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Asad Zaheer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chrysostomos Dimitriou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Symeon Nicolaou.

Ethics declarations

Conflict of interest

The authors report no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nicolaou, S., Khatib, T.Z., Lin, Z. et al. A retrospective review of XEN implant surgery: efficacy, safety and the effect of combined cataract surgery. Int Ophthalmol 42, 881–889 (2022). https://doi.org/10.1007/s10792-021-02069-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-021-02069-5

Keywords

Search

Navigation